Ondansetron
Product Images NDC 53002-0580

4 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 53002-0580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530020580)

Label Image (Lbl530020580)
Ondansetron 4 mg OD Tablets packaging label from RPK Pharmaceuticals, Inc., showing a 10-tablet bottle. The label includes directions for use, barcode, lot number, expiration date, and instructions for taking the tablets as directed by a prescriber.*
FDA Label Image
FDA Label Image

Structure-base (Structure Base)

Structure-base (Structure Base)
Chemical structure diagram of the active ingredient Ondansetron, showing its characteristic fused ring system with attached functional groups.*
FDA Label Image

Structure-hcl (Structure HCl)

Structure-hcl (Structure HCl)
Chemical structure of Ondansetron hydrochloride dihydrate, showing the molecular arrangement including the indole and imidazole rings, with associated chlorine and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.